Budak , et al
Where clinically indicated and after eligibility screening: Mounjaro (tirzepatide), Ozempic and Wegovy (semaglutide injectable), and generic semaglutide (post-March 2026 from Sun Pharma, Zydus, Dr
Over the next five years, the marketplace will only grow more crowded: cheaper generics, oral pills replacing injections, and an escalating marketing war as companies expand indications from diabetes and obesity into sleep apnea, fatty liver disease, even addiction
A small group of users should avoid copper peptides entirely, including those with copper sensitivity, active inflammatory conditions, and pregnancy
As demand for weight loss and diabetes drugs spikes, more digital health companies are offering compounded GLP-1s as a cheaper alternative for consumers, intensifying competition in the market
Patients then paid between $500 and $3000 to the scam pharmacy, receiving either no product or vials of red liquid